Suggestions
Louis Roy
CEO Optel Group - BCorp
Louis Roy is the founder and owner of Optel Group, a BCorp and a global leader in cradle-to-grave traceability solutions with operations in Canada, USA, Brazil, Ireland, and India.
Passionate about making a positive impact on society, Louis aligns his personal mission of using disruptive technologies to create a better world with the business goals of Optel Group.
Under Louis Roy's leadership, Optel Group has transitioned towards deploying end-to-end traceability solutions to create the Intelligent Supply Chain®, benefiting both businesses and humanity.
Louis has spearheaded the development of innovative consumer engagement tools like gamification, loyalty programs, and mobilization tools to connect consumers with Optel Group's traceability platform.
As a BCorp, Optel Group under Louis Roy's guidance focuses on being a model for future entrepreneurs and contributing to building a sustainable and socially responsible world, emphasizing the triple bottom line of Profit, Planet, and People.
Louis Roy and Optel Group actively participate in initiatives with organizations like the World Economic Forum (WEF), United Nations (UN), World Health Organization (WHO), United Nations Educational, Scientific and Cultural Organization (UNESCO), universities, and public institutions to further the sustainability movement.
Highlights
Real use case on leveraging traceability for sustainability and supply chain performance. Traceability is a key enabler for circular economy. OPTEL's solutions are already used in recycle content for plastics, metals, and soon in the EV battery value chain. #traceability #CircularEconomy #sustainability
Transforming Pharma Compliance into ESG-GHG Traceability Excellence
In the pharmaceutical industry, the rigorous standards of the FDA-DSCSA and EU Falsified Medicine Directive have not just ensured product integrity; they've laid the groundwork for our next leap: ESG-GHG traceability. These stringent compliance frameworks are more than regulatory achievements; they are the blueprints for embedding sustainability into our operations.
Our journey from compliance to environmental stewardship is both a strategic imperative and a testament to our commitment to global health. Leveraging the robust infrastructure and sophisticated technologies developed for DSCSA and EU compliance, we're poised to accelerate ESG-GHG traceability, enhancing operational efficiency and corporate responsibility.
As industry leaders, it's our moment to pivot from ensuring medicine integrity to championing planetary health. This synergy between regulatory adherence and environmental traceability isn't just an alignment; it's a transformative stride towards a sustainable, traceable, and responsible pharma industry.
#PharmaSustainability #ESG #GHG #Traceability #FDADSCSA #FalsifiedMedicineDirective #SustainablePharma
